Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castrate-resistant Metastatic Prostate Cancer”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Not applicableStudy completedNCT03329742
What this trial is testing

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Indiana University 2
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Large-scale testing (Phase 3)Looking for participantsNCT06470243
What this trial is testing

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network 528
Post-approval studies (Phase 4)Looking for participantsNCT06099093
What this trial is testing

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Carcinoma
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06927635
What this trial is testing

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Who this might be right for
Castrate Resistance Prostate CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 75
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Testing effectiveness (Phase 2)Looking for participantsNCT05766371
What this trial is testing

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
University of California, San Francisco 48
Early research (Phase 1)Study completedNCT01792687
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 6
Not applicableStudy completedNCT01812668
What this trial is testing

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT01558492
What this trial is testing

Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 3
Large-scale testing (Phase 3)Active Not RecruitingNCT04647526
What this trial is testing

Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 455
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Testing effectiveness (Phase 2)WithdrawnNCT01188408
What this trial is testing

Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
INSYS Therapeutics Inc
Early research (Phase 1)Study completedNCT03076203
What this trial is testing

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneStage IV Prostate AdenocarcinomaHormone-refractory Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT00853697
What this trial is testing

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant, Metastatic
Memorial Sloan Kettering Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Not applicableStudy completedNCT02236637
What this trial is testing

A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 3,050
Testing effectiveness (Phase 2)UnknownNCT02266745
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Who this might be right for
Advanced Solid TumorsCRPCmCRPC+6 more
Promontory Therapeutics Inc. 109
Testing effectiveness (Phase 2)Study completedNCT01818986
What this trial is testing

Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castrate-resistant Prostate CancermCRPC
University of Texas Southwestern Medical Center 20
Next Page